AURORA (PET MPI)

A Phase 3, Open-Label, Multicentre Study of Flurpiridaz Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography Because of Suspected Coronary Artery Disease

Stadium
klaar
Middel
flurpiridaz, injection
Populatie
ASCVD
Fase
III
First Patient In
1 mei 2019
Last Patient In
31 maart 2022
Last Patient Last Visit
12 april 2022

National Lead

dr. J. Schaap

Cardioloog

Contact Kantoor

S. Jansen

Studiemanager

De pagina is verlopen.